DR. GREG GORDON M.D.
FOUNDER/CHIEF MEDICAL OFFICER
Originally from Chicago, Dr. Gordon received his undergraduate training at the University of Illinois Champaign-Urbana, with a B.S degree in biochemistry. He performed his medical school training at the University of Illinois Medical School at Chicago. His post doctorate training, including an internship in internal medicine, residency in diagnostic radiology, and fellowship in vascular and interventional radiology, were all completed at Northwestern University. Dr. Gordon has 20 years experience in both private and academic practices, including five years as division head of interventional radiology at Saint Luke’s Hospital/ UMKC medical school Kansas City, Missouri. More recently, Dr. Gordon served as Division Head of Interventional Radiology at the University of Nebraska Medical Center. Soon after starting Radux Devices, Dr. Gordon refocused his attention to the Omaha Veterans Hospital as Director of Interventional Radiology, and in private practicedevoted more energy towards his entrepreneurial passions, focusing and promoting standardized occupational and radiation risk management strategies throughout national health care systems.
In addition to his career as a physician, Dr. Gordon has published multiple peer review articles and is a frequent speaker at educational symposiums and continuing medical education venues. His interests in innovation, intellectual property and practice development have provided Dr. Gordon the opportunity to be primary investigator in multiple clinical medical device trials. Through his partnership with UNeMed, Dr. Gordon founded and developed the first two product concepts of Radux Devices, the StandTall and LockBlock.
CHIEF EXECUTIVE OFFICER
Kevin Wiersma is a proven executive with over 25 years of experience driving strategic, financial, and operating results. Kevin has provided leadership to companies through various phases from turnaround situations to successful sales and exits. Prior to Radux Devices, Kevin held positions as Chief Financial Officer, Chief Operating Officer, and Chief Administrative Office at MEDTOX Scientific, Inc. and Chief Financial Officer at Therapak Corporation.
Kevin has a B.A. degree from Dordt College.
Hillari oversees all Business Operations which includes Sales and Marketing.
For over 20 years, Hillari worked as Executive Director of Strategic Partnerships for Chiltern, a Clinical Research Organization (CRO) managing many of the company’s top global client relationships such as Eli Lilly, Abbott, Abbvie, Pfizer and Astellas. In this role, she was responsible for all aspects of client interface including the creation of competitive pricing models, proposals and terms, negotiating multi-year contracts and strategies necessary for meeting company divisional goals. Hillari has served on several internal Advisory Boards and was a key member of the Device and Diagnostic Business Unit Committee.
She is a recognized speaker at many industry conferences and participated in numerous panel discussions about global client management. Her prior experience involved working as Corporate Account Manager for Celsis International, a Diagnostic Company where she was instrumental in working with the executive team to develop and implement a Value Improvement Partnership Program to help drive global expansion and enhance communication with key accounts.
Hillari has a B.S. degree from Michigan State University.
Ms. Swanson entered the Cardiovascular Device space in 1995 and is a career regulatory and clinical professional who provides global, strategic regulatory solutions for medical devices at all stages of development in the product life cycle. With more than 22 years of experience in the health products industry designing strategies, which expedite progress to market and extend market life, Ms. Swanson brings her broad knowledge and clinical insights to Radux Devices. Ms. Swanson was most recently Senior Director, Regulatory Affairs and Clinical Research at Vascular Solutions where she was responsible for building and maintaining the regulatory infrastructure to support multiple product lines for interventional cardiology/radiology, vein ablation, and hemostatic products. Her key leadership role included developing, implementing and directing regulatory strategies for securing worldwide market authorization for Class II products. Ms. Swanson has also served as an interface with the FDA and international regulatory agencies and has developed quality systems and participated in bioresearch monitoring audits to ensure regulatory approval for numerous submissions.
Ms. Swanson received her undergraduate degree in biotechnology from Minnesota State University-Mankato.
Alan VanHouten got his start working with interventional cardiology companies in 1996 as a quality engineer and later as a project engineer. Alan is an experienced Senior Project Engineer with expertise in all areas related to bringing new single-use medical devices to market and into high volume production. Most of his background is working with Class II medical device companies and helping move into the commercialization phase and beyond. In addition to his broad view of project management as it relates to quality production and system implementation, Alan will assist Radux Devices with details such as identifying specifications of mechanical components. Alans key responsibilities include: process validation, developing a Quality system which is compliant with ISO 13485 & MDD, Risk Management Files and electrical safety certification 60601-1. Alan is also a certified auditor for ISO 13485:2016.
Alan has a B.S. Degree from Winona State University.